摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(benzyloxy)-1-(1,2,3,4-tetrahydropyrido[4',3':4,5]imidazo[1,2-a]pyridin-7-yl)pyridin-2(1H)-one monohydrochloride | 1382804-83-2

中文名称
——
中文别名
——
英文名称
4-(benzyloxy)-1-(1,2,3,4-tetrahydropyrido[4',3':4,5]imidazo[1,2-a]pyridin-7-yl)pyridin-2(1H)-one monohydrochloride
英文别名
4-(Benzyloxy)-1-(1,2,3,4-tetrahydropyrido[4',3':4,5]imidazo[1,2-a]pyridin-7-yl)pyridin-2(1H)-one hydrochloride;4-phenylmethoxy-1-(1,4,8-triazatricyclo[7.4.0.02,7]trideca-2(7),8,10,12-tetraen-11-yl)pyridin-2-one;hydrochloride
4-(benzyloxy)-1-(1,2,3,4-tetrahydropyrido[4',3':4,5]imidazo[1,2-a]pyridin-7-yl)pyridin-2(1H)-one monohydrochloride化学式
CAS
1382804-83-2
化学式
C22H20N4O2*ClH
mdl
——
分子量
408.887
InChiKey
ZKNFZPNNQGIXPC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.13
  • 重原子数:
    29
  • 可旋转键数:
    4
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    58.9
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    参考文献:
    名称:
    TETRAHYDRO-AZACARBOLINE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USES THEREOF
    摘要:
    本发明涉及式(I)的四氢-吖啶咔啉衍生物,其具有如本文所述的取代基,这些取代基是黑素浓缩激素(MCH-1)受体拮抗剂。本发明还涉及包括这些化合物的药物组合物,以及其制备和使用方法。
    公开号:
    US20120157460A1
  • 作为产物:
    描述:
    tert-butyl 7-(4-(benzyloxy)-2-oxopyridin-1(2H)-yl)-3,4-dihydropyrido[4',3':4,5]imidazo[1,2-a]pyridine-2(1H)-carboxylate 、 盐酸 以to provide the title compound (340 mg, 82%) as a white solid的产率得到4-(benzyloxy)-1-(1,2,3,4-tetrahydropyrido[4',3':4,5]imidazo[1,2-a]pyridin-7-yl)pyridin-2(1H)-one monohydrochloride
    参考文献:
    名称:
    TETRAHYDRO-AZACARBOLINE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USES THEREOF
    摘要:
    本发明涉及式(I)的四氢-氮杂环己烷衍生物,其具有如此处所述的取代基,这些取代基是黑色素浓集激素(MCH-1)受体拮抗剂。本发明还涉及包括这些化合物的药物组合物,以及其制备和使用方法。
    公开号:
    US20120157460A1
点击查看最新优质反应信息

文献信息

  • US8993765B2
    申请人:——
    公开号:US8993765B2
    公开(公告)日:2015-03-31
  • [EN] TETRAHYDRO-AZACARBOLINE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USES THEREOF<br/>[FR] ANTAGONISTES DE LA MCH-1 À BASE DE TÉTRAHYDRO-AZACARBOLINE, LEURS PROCÉDÉS DE FABRICATION ET LEURS UTILISATIONS
    申请人:ALBANY MOLECULAR RES INC
    公开号:WO2012088124A2
    公开(公告)日:2012-06-28
    The present invention relates to tetrahydro-azacarboline derivatives of formula (I) having the substituents as described herein which are melanin-concentrating hormone (MCH-1) receptor antagonists. The present invention also relates to pharmaceutical compositions including these compounds, and methods of preparation and use thereof.
  • TETRAHYDRO-AZACARBOLINE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USES THEREOF
    申请人:SURMAN Matthew D.
    公开号:US20120157460A1
    公开(公告)日:2012-06-21
    The present invention relates to tetrahydro-azacarboline derivatives of formula (I): having the substituents as described herein which are melanin-concentrating hormone (MCH-1) receptor antagonists. The present invention also relates to pharmaceutical compositions including these compounds, and methods of preparation and use thereof.
    本发明涉及式(I)的四氢-吖啶咔啉衍生物,其具有如本文所述的取代基,这些取代基是黑素浓缩激素(MCH-1)受体拮抗剂。本发明还涉及包括这些化合物的药物组合物,以及其制备和使用方法。
  • Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof
    申请人:Surman Matthew D.
    公开号:US08993765B2
    公开(公告)日:2015-03-31
    The present invention relates to tetrahydro-azacarboline derivatives of formula (I): having the substituents as described herein which are melanin-concentrating hormone (MCH-1) receptor antagonists. The present invention also relates to pharmaceutical compositions including these compounds, and methods of preparation and use thereof.
    本发明涉及式(I)的四氢-杂环喹啉衍生物,其取代基如此处所述,这些衍生物是黑色素浓集激素(MCH-1)受体拮抗剂。本发明还涉及包括这些化合物的制药组合物以及其制备和使用方法。
查看更多

同类化合物

3H-1,4,8B-三氮杂苊烯e-3,5(4H)-二酮 3,4-bis(hydroxymethyl)dipyrido[1,2-a;3',4'-d]imidazole 3-methyldipyrido[1,2-a;3',4'-d]imidazole 2-methyl-6,7,8,9-tetrahydropyrido<1,2-a>benzimidazole 6,7,8,9-tetrahydrobenzo[4,5] imidazo[1,2-a]pyridin-3-amine 3-bromo-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridine N-[1-[3-(3-cyanophenyloxy)propan-1-yl]piperidin-4-yl]-5-thia-1,8b-diazaacenaphthylene-4-carboxamide N-[1-[3-(2-cyanophenyloxy)propan-1-yl]piperidin-4-yl]-5-thia-1,8b-diazaacenaphthylene-4-carboxamide 4,5-dihydro-4-[4-(tert-butoxycarbonylamino)butan-1-yl]-3H-1,4,8b-triazaacenaphthylene-3,5-dione diethyl 5-hydroxy-3-thia-1,8b-diazaacenaphthylene-2,4-dicarboxylate 5-thia-1,8b-diazaacenaphthylene-4-carbaldehyde 2-bromo-7,8-dihydrobenzo[4,5]imidazo[1,2-a]pyridin-9(6H)-one 2-(2-morpholinopyrimidin-5-yl)-7,8-dihydrobenzo[4,5]imidazo[1,2-a]pyridin-9(6H)-one 9H-imidazo[1,2-a]pyrrolo[2,3-c]pyridine 8-chloro-1-[2-(difluoromethoxy)phenyl]-3,4-dihydro-1H-pyrano[4',3':4,5]imidazo[1,2-a]pyridine 6-methoxymethyl-2,3-dimethyl-9-phenyl-7,8,9,10-tetrahydro-imidazo[2,1-a]isoquinoline 4,5-dihydro-4-(tert-butoxycarbonyl)-3H-1,4,8b-triazaacenaphthylen-3-one imidazo<4',5':4,5>imidazo<1,2-a>pyridine">1,10-diethylpyrido<1",2":1',2'>imidazo<4',5':4,5>imidazo<1,2-a>pyridine imidazo<4',5':4,5>imidazo<1,2-a>pyridine">1,10-dimethylpyrido<1",2":1',2'>imidazo<4',5':4,5>imidazo<1,2-a>pyridine 1,3,4-trifluoro-dipyrido[1,2-a;3',4'-d]imidazole 3-(cyclopropyl)pyrano[3',4':4,5]imidazo[1,2-a]pyridinone 3-[(N-benzyl-N-methylamino)methyl]pyrano-[3',4':4,5]imidazo[1,2-a]pyridin-1-one 2-chloro-8-hydroxymethylene-6,7,8,9-tetrahydropyrido[1,2-a]benzimidazol-9-one ethyl 7-nitro-1H-imidazo<1,2-a>pyrazolo<3,4-c>pyridine-8-carboxylate 1-oxopyrido(1',2':1,2)imidazo[5,4-d]-1,2,3-triazine 3-methyl-2-[5-(amino)pentan-1-ylthio]-1,4,7b-triazacyclopent[cd]indene 1-methyl-3-pentyldipyrido[1,2-a:3',4'-d]imidazole 3-cyclopropyl-1-methyldipyrido[1,2-a:3',4'-d]imidazole 8-oxo-2,7,9-trimethylimidazo<4.5-c>imidazo<1.2-a>pyridine 1,3,7b-triazacyclopentinden-4(3H)-one 2-(2'-adamantyl)-8-oxo-7,9-dimethylimidazo<4.5-c>imidazo<1.2-a>pyridine ((7R,8S)-3-(1,3,4-oxadiazol-2-yl)-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridin-8-yl)carbamate (7R,8S)-3-(1,2,4-oxadiazol-5-yl)-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridin-8-amine tert-butyl ((7R,8S)-3-(1H-tetrazol-5-yl)-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridin-8-yl)carbamate tert-butyl ((7R,8S)-3-(4-methyl-5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridin-8-yl)carbamate tert-butyl ((7R,8S)-3-(2-methyl-2H-tetrazol-5-yl)-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridin-8-yl)carbamate (7R,8S)-3-(2-methyl-2H-tetrazol-5-yl)-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridin-8-amine 5-((7R,8S)-8-amino-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridin-3-yl)-3-methyl-1,3,4-oxadiazol-2(3H)-one tert-butyl ((7R,8S)-3-(4-methyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridin-8-yl)carbamate tert-butyl ((7R,8S)-3-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridin-8-yl)carbamate 5-((7R,8S)-8-amino-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridin-3-yl)-1,2,4-oxadiazol-5(4H)-one tert-butyl ((7R,8S)-3-((Z)-carbamohydrazonoyl)-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridin-8-yl)carbamate (7R,8S)-8-amino-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridine-4-carbonitrile (7R,8S)-3-(1,2,4-oxadiazol-3-yl)-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridin-8-amine 3-((7R,8S)-8-amino-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridin-3-yl)-4-methyl-1,2,4-oxadiazol-5(4H)-one ((7R,8S)-3-(1H-tetrazol-5-yl)-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridin-8-yl)carbamate (7R,8S)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridin-8-amine tert-butyl ((7R,8S)-3-(5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridin-8-yl)carbamate tert-butyl ((7R,8S)-3-cyano-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridin-8-yl)carbamate (7R,8S)-3-(1,3,4-oxadiazol-2-yl)-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridin-8-amine